Search research articles
Contact Us
Filters
Showing results (131-140 of 266) with videos related to
Page
of 27
Sort By:
Therapeutic Advances in Neurological Disorders
|
October 4, 2021
No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)
Helmut Butzkueven, Ludwig Kappos, Tim Spelman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2020
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, et al.
Journal of Clinical Microbiology
|
November 4, 2016
Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection
Trisha N Peel, Tim Spelman, Brenda L Dylla, et al.
Haematologica
|
November 8, 2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
Michelle R Ananda-Rajah, Andrew Grigg, Maria T Downey, et al.
Sexual Health
|
May 20, 2011
Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources
Judy Gold, Jane Goller, Margaret Hellard, et al.
Frontiers in Immunology
|
October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling
Benjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Current Neuropharmacology
|
March 25, 2026
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase
Aurora Zanghì, Tim Spelman, Marzena Fabis-Pedrini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 16, 2020
Burden and clinical outcomes of hospital-coded infections in patients with cancer: an 11-year longitudinal cohort study at an Australian cancer centre
Jake C Valentine, Lisa Hall, Tim Spelman, et al.
The Australian and New Zealand Journal of Psychiatry
|
May 27, 2023
Childhood trauma is prevalent and associated with co-occurring depression, anxiety, mania and psychosis in young people attending Australian youth mental health services
Sarah Bendall, Oliver Eastwood, Tim Spelman, et al.
Plos One
|
August 23, 2013
Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study
Jane E Greig, Philipp A du Cros, Clair Mills, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 266) with videos related to
Sort By:
Page
of 27
Therapeutic Advances in Neurological Disorders
|
October 4, 2021
No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)
Helmut Butzkueven, Ludwig Kappos, Tim Spelman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2020
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, et al.
Journal of Clinical Microbiology
|
November 4, 2016
Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection
Trisha N Peel, Tim Spelman, Brenda L Dylla, et al.
Haematologica
|
November 8, 2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
Michelle R Ananda-Rajah, Andrew Grigg, Maria T Downey, et al.
Sexual Health
|
May 20, 2011
Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources
Judy Gold, Jane Goller, Margaret Hellard, et al.
Frontiers in Immunology
|
October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling
Benjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Current Neuropharmacology
|
March 25, 2026
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase
Aurora Zanghì, Tim Spelman, Marzena Fabis-Pedrini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 16, 2020
Burden and clinical outcomes of hospital-coded infections in patients with cancer: an 11-year longitudinal cohort study at an Australian cancer centre
Jake C Valentine, Lisa Hall, Tim Spelman, et al.
The Australian and New Zealand Journal of Psychiatry
|
May 27, 2023
Childhood trauma is prevalent and associated with co-occurring depression, anxiety, mania and psychosis in young people attending Australian youth mental health services
Sarah Bendall, Oliver Eastwood, Tim Spelman, et al.
Plos One
|
August 23, 2013
Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study
Jane E Greig, Philipp A du Cros, Clair Mills, et al.
Page
of 27